Autoimmune Hepatitis Diagnosis and Treatment Market
Autoimmune Hepatitis Diagnosis and Treatment Market Size, Share & Trends Analysis Report By Diagnosis (Blood Test, Imaging Test, Liver Biopsy) By Treatment (Medication, Corticosteroids, Immune System Suppressors, Liver Transplant), By Type (Type-I, Type-II, Variant AIH) End-User (Hospitals & Clinics, Diagnostic Centre, and Research Institutions), Forecast Period (2026-2035)
Industry Overview
Autoimmune hepatitis diagnosis and treatment market was valued at $2,211.7 million in 2025 and is projected to reach $3,001.1 million by 2035, growing at a CAGR of 3.2% during the forecast period (2026-2035). The global autoimmune hepatitis diagnosis and treatment market is witnessing steady growth driven by increasing awareness of liver-related autoimmune disorders and advancements in diagnostic technologies. Improved availability of specialized healthcare facilities and rising adoption of precision medicine are enhancing early detection and effective management of the disease. Continuous research and development efforts are contributing to the introduction of novel therapies and treatment options. The growing prevalence of autoimmune disorders and liver complications is further fueling demand for innovative diagnostic tools and therapeutic solutions. Additionally, supportive government initiatives and the development of healthcare infrastructure are facilitating greater access to care.
Market Dynamics
Increasing Adoption of Advanced Diagnostic Technologies
The global autoimmune hepatitis diagnosis and treatment market is experiencing a shift toward advanced diagnostic technologies, including high-sensitivity blood tests and non-invasive imaging techniques. These innovations enable earlier and more accurate detection of liver inflammation and autoimmune activity, improving patient outcomes. Growing demand for personalized treatment plans is encouraging healthcare providers to integrate these cutting-edge diagnostic solutions. Moreover, technological advancements are reducing dependence on invasive procedures, making diagnosis more patient-friendly. Expansion of diagnostic laboratories and increased investment in research are further supporting market growth.
Development of Targeted Therapeutic Options
There is a growing focus on developing targeted therapies for autoimmune hepatitis, driven by advances in immunology and biologic drug development. Pharmaceutical companies are increasingly investing in novel immunosuppressant and combination therapies to improve efficacy and minimize side effects. The rising prevalence of autoimmune disorders and liver complications is intensifying the need for more effective treatment regimens. Additionally, regulatory support and clinical trial initiatives are accelerating the introduction of innovative drugs to the market.
Market Segmentation
- Based on the diagnosis, the market is segmented, blood test, imaging test, and liver biopsy.
- Based on the treatment, the market is segmented into medication, corticosteroids, immune system suppressors and liver transplant.
- Based on the type, the market is segmented into type I, type II and variant AIH.
- Based on the end user, the market is segmented into hospitals and clinics, diagnostic centers and research institutions.
Blood Test Segment to Lead the Market with the Largest Share
The growth of the global autoimmune hepatitis diagnosis and treatment market is largely driven by the increasing utilization of blood tests. These tests provide a reliable, non-invasive, and efficient method for detecting liver inflammation and autoimmune activity, allowing for timely diagnosis. Enhanced accuracy in identifying disease markers through blood analysis has improved patient outcomes and guided targeted treatment strategies. Rising adoption of these tests in clinical practice is supported by advancements in laboratory technology and testing protocols. Moreover, the accessibility and cost-effectiveness of blood tests make them a preferred choice for healthcare providers worldwide.
Type 1: A Key Segment in Market Growth
The growth of the global autoimmune hepatitis diagnosis and treatment market is largely supported by the high prevalence of Type 1 autoimmune hepatitis. This subtype accounts for the majority of diagnosed cases, creating a consistent demand for specialized diagnostic and therapeutic interventions. Increased recognition of Type 1 disease patterns has prompted healthcare providers to implement targeted screening and monitoring strategies. Advancements in treatment protocols tailored to Type 1 patients have further improved clinical outcomes and patient quality of life. The concentration of Type 1 cases in both developed and emerging regions has driven broader market adoption of relevant therapies.
Regional Outlook
The global autoimmune hepatitis diagnosis and treatment market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Rising Awareness and Advanced Diagnostics Driving Europe’s Autoimmune Hepatitis Market
The autoimmune hepatitis diagnosis and treatment market in Europe is experiencing steady growth driven by the increasing prevalence of liver-related autoimmune disorders. Enhanced awareness among healthcare professionals and patients has led to earlier diagnosis and more effective management strategies. Advanced diagnostic technologies, including high-precision blood tests and imaging tools, are improving detection rates and guiding treatment decisions. Supportive healthcare infrastructure and the availability of specialized treatment centers have facilitated better patient access to care.
Asia-Pacific Region Dominates the Market with Major Share
The autoimmune hepatitis diagnosis and treatment market in North America is expanding steadily due to the growing prevalence of liver autoimmune disorders. Widespread adoption of advanced diagnostic techniques, including high-sensitivity blood tests and imaging tools, has improved early detection and disease management. Increased awareness among healthcare providers and patients has facilitated timely interventions and more effective treatment strategies. The presence of well-established healthcare infrastructure and specialized treatment centers has enhanced accessibility to care.
Market Players Outlook
The major companies operating in the global autoimmune hepatitis diagnosis and treatment market include Abbott Laboratories (Abbot Corp.), AbbVie Inc., AstraZeneca plc, Pfizer Inc. and Siemens Healthineers AG, among others. Market players are leveraging partnerships, collaborations, mergers and acquisitions strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In July 2025, Siemens Healthineers formally partnered with Apollo Hospitals to advance innovation in liver healthcare through research. This directly supports the Imaging Test segment of AIH by enhancing non-invasive assessment of liver fibrosis and cirrhosis—the main consequence of untreated AIH.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global autoimmune hepatitis diagnosis and treatment. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Hepatitis Diagnosis and Treatment Market Sales Analysis – Diagnosis| Treatment| Type | End User | ($ Million)
- Hepatitis Diagnosis and Treatment Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Hepatitis Diagnosis and Treatment Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Hepatitis Diagnosis and Treatment Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Hepatitis Diagnosis and Treatment Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Hepatitis Diagnosis and Treatment Market: Impact Analysis
- Market Opportunities
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Hepatitis Diagnosis and Treatment Market Revenue and Share by Manufacturers
- Hepatitis Diagnosis and Treatment Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Abbott Laboratories (Abbot Corp.)
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- AbbVie Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- AstraZeneca plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Pfizer Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Siemens Healthineers AG
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Abbott Laboratories (Abbot Corp.)
- Key Company Analysis
- Global Hepatitis Diagnosis and Treatment Market Sales Analysis by Diagnosis ($ Million)
- Blood Test
- Imaging Test
- Liver Biopsy
- Global Hepatitis Diagnosis and Treatment Market Sales Analysis by Treatment ($ Million)
- Medication
- Corticosteroids
- Immune System Suppressors
- Liver Transplant
- Global Hepatitis Diagnosis and Treatment Market Sales Analysis by End User ($ Million)
- Hospitals and Clinics
- Diagnostic Centre
- Research Institutions
- Regional Analysis
- North American Hepatitis Diagnosis and Treatment Market Sales Analysis – Diagnosis| Treatment| Type | End User| Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Hepatitis Diagnosis and Treatment Market Sales Analysis – Diagnosis| Treatment| Type |End User| Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Hepatitis Diagnosis and Treatment Market Sales Analysis – Diagnosis| Treatment| Type | End User| Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Hepatitis Diagnosis and Treatment Market Sales Analysis –Diagnosis| Treatment| Type | End User| Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories (Abbot Corp.)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AbbVie Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AstraZeneca plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bio-Rad Laboratories, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Falk Pharma GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- EUROIMMUN Medizinische Labordiagnostika AG (Revvity, Inc.)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hoffmann-La Roche Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Inova Labs Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- labcorp (Laboratory Corporation of America Holdings)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Max Lab Ltd. (Max Healthcare Institute Ltd)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medanta (Global Health Ltd.)
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Novartis AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Pfizer Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Quest Diagnostics Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Quest Diagnostics Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sandoz Group AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sanofi S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Siemens Healthineers AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zydus Lifesciences Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories (Abbot Corp.)
1. Global Autoimmune Hepatitis Diagnosis And Treatment Market Research And Analysis By Diagnosis, 2025-2035 ($ Million)
2. Global Autoimmune Hepatitis Diagnosis And Treatment For Blood Test Market Research And Analysis By Region, 2025-2035 ($ Million)
3. Global Autoimmune Hepatitis Diagnosis And Treatment For Imaging Test Market Research And Analysis By Region, 2025-2035 ($ Million)
4. Global Autoimmune Hepatitis Diagnosis And Treatment For Liver Biopsy Market Research And Analysis By Region, 2025-2035 ($ Million)
5. Global Autoimmune Hepatitis Diagnosis And Treatment Market Research And Analysis By Treatment, 2025-2035 ($ Million)
6. Global Autoimmune Hepatitis Diagnosis And Treatment For Medication Market Research And Analysis By Treatment, 2025-2035 ($ Million)
7. Global Autoimmune Hepatitis Diagnosis And Treatment For Corticosteroids Market Research And Analysis By Region, 2025-2035 ($ Million)
8. Global Autoimmune Hepatitis Diagnosis And Treatment For Immune System Suppressors Market Research And Analysis By Region, 2025-2035 ($ Million)
9. Global Autoimmune Hepatitis Diagnosis and Treatment For Liver Transplant Market Research and Analysis by Region, 2025-2035 ($ million)
10. Global Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Type, 2025-2035 ($ million)
11. Global Type-I Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Region, 2025-2035 ($ million)
12. Global Type-II Autoimmune Hepatitis Diagnosis and Treatment Market Research and analysis by Region, 2025-2035 ($ million)
13. Global Variant AIH Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Region, 2025-2035 ($ million)
14. Global Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by End-User, 2025-2035 ($ million)
15. Global Autoimmune Hepatitis Diagnosis And Treatment For Hospitals And Clinics Market Research And Analysis By Region, 2025-2035 ($ Million)
16. Global Autoimmune Hepatitis Diagnosis And Treatment For Diagnostic Centre Market Research And Analysis By Region 2025-2035 ($ Million)
17. Global Autoimmune Hepatitis Diagnosis And Treatment For Research Institutions Market Research And Analysis By Region 2025-2035 ($ Million)
18. Global Autoimmune Hepatitis Diagnosis And Treatment Market Research and Analysis by Geography, 2025-2035 ($ million)
19. North American Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Country, 2025-2035 ($ million)
20. North American Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Diagnosis, 2025-2035 ($ million)
21. North American Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Treatment, 2025-2035 ($ million)
22. North American Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Type, 2025-2035 ($ million)
23. North American Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by End-User, 2025-2035 ($ million)
24. European Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Country, 2025-2035 ($ million)
25. European Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Diagnosis, 2025-2035 ($ million)
26. European Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Treatment, 2025-2035 ($ million)
27. European Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Type, 2025-2035 ($ million)
28. European Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by End-User, 2025-2035 ($ million)
29. Asia-Pacific Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Country, 2025-2035 ($ million)
30. Asia-Pacific Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Diagnosis, 2025-2035 ($ million)
31. Asia-Pacific Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Treatment, 2025-2035 ($ million)
32. Asia-Pacific Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Type, 2025-2035 ($ million)
33. Asia-Pacific Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by End-User, 2025-2035 ($ million)
34. Rest of the World Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Region, 2025-2035 ($ million)
35. Rest of the World Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Diagnosis, 2025-2035 ($ million)
36. Rest of the World Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Treatment, 2025-2035 ($ million)
37. Rest of the World Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Type, 2025-2035 ($ million)
38. Rest of the World Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by End-User, 2025-2035 ($ million)
1. Global Autoimmune Hepatitis Diagnosis and Treatment Market Share by Diagnosis, 2025 Vs 2035 (%)
2. Global Autoimmune Hepatitis Diagnosis and Treatment For Blood Test Market Share by Region, 2025 Vs 2035 (%)
3. Global Autoimmune Hepatitis Diagnosis And Treatment For Imaging Test Market Share by Region, 2025 Vs 2035 (%)
4. Global Autoimmune Hepatitis Diagnosis and Treatment For Liver Biopsy Market Share by Region, 2025 Vs 2035 (%)
5. Global Autoimmune Hepatitis Diagnosis and Treatment Market Share by Treatment, 2025 Vs 2035 (%)
6. Global Autoimmune Hepatitis Diagnosis and Treatment For Medication Market Share by Region, 2025 Vs 2035 (%)
7. Global Autoimmune Hepatitis Diagnosis and Treatment For Corticosteroids Market Share by Region, 2025 Vs 2035 (%)
8. Global Autoimmune Hepatitis Diagnosis and Treatment For Immune System Suppressors Market Share by Region, 2025 Vs 2035 (%)
9. Global Autoimmune Hepatitis Diagnosis and Treatment in Liver Transplant Market Share by Region, 2025 Vs 2035 (%)
10. Global Autoimmune Hepatitis Diagnosis and Treatment Market Share by Type, 2025 Vs 2035 (%)
11. Global Type-I Autoimmune Hepatitis Diagnosis and Treatment Market Share by Region, 2025 Vs 2035 (%)
12. Global Type-II Autoimmune Hepatitis Diagnosis and Treatment Market Share by Region, 2025 Vs 2035 (%)
13. Global Variant AIH Autoimmune Hepatitis Diagnosis and Treatment Market Share by Region, 2025 Vs 2035 (%)
14. Global Autoimmune Hepatitis Diagnosis and Treatment Market Share by End User, 2025 Vs 2035 (%)
15. Global Autoimmune Hepatitis Diagnosis and Treatment For Hospitals and Clinics Market Share by Region, 2025 Vs 2035 (%)
16. Global Autoimmune Hepatitis Diagnosis and Treatment For Diagnostic Centre Market Share by Region, 2025 Vs 2035 (%)
17. Global Autoimmune Hepatitis Diagnosis and Treatment For Research Institutions Market Share by Region, 2025 Vs 2035 (%)
18. Global Autoimmune Hepatitis Diagnosis and Treatment Market Research and Analysis by Region, 2025–2035 ($ Million)
19. US Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
20. Canada Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
21. UK Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
22. France Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
23. Germany Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
24. Italy Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
25. Spain Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
26. Russia Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
27. Rest of Europe Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
28. India Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
29. China Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
30. Japan Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
31. South Korea Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
32. Australia and New Zealand Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
33. ASEAN Economies Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
34. Rest of Asia-Pacific Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
35. Latin America Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
36. Middle East and Africa Hepatitis Diagnosis and Treatment Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of user within the company
Contact Sales
FAQS
The size of the Autoimmune Hepatitis Diagnosis and Treatment Market in 2025 is estimated to be around $2,211.7 million.
Asia-Pacific holds the largest share in the Autoimmune Hepatitis Diagnosis and Treatment Market.
Leading players in the Autoimmune Hepatitis Diagnosis and Treatment Market include Abbott Laboratories (Abbot Corp.), AbbVie Inc., AstraZeneca plc, Pfizer Inc. and Siemens Healthineers AG, among others.
Autoimmune Hepatitis Diagnosis and Treatment Market is expected to grow at a CAGR of 3.2% from 2026 to 2035.
The market is growing due to increasing autoimmune disease prevalence, better diagnostic tools, higher awareness, and improved immunosuppressive treatments.
